Literature DB >> 20084569

Utility of esophageal manometry and pH-metry in gastroesophageal reflux disease before surgery.

Filiz Akyüz1, Serpil Arici, Fatih Ermiş, Zeynel Mungan.   

Abstract

BACKGROUND/AIMS: The necessity of manometric evaluation before fundoplication in patients with gastroesophageal reflux disease is still a matter of debate. However, misdiagnosis can be responsible for postoperative problems. We aimed to evaluate the necessities of manometry and pH-metry before fundoplication in order to prevent possible complications after surgery.
METHODS: Between 1997 and 2004, 259 consecutive patients who referred to our laboratory with a diagnosis of gastroesophageal reflux disease and request for manometric test before surgery were evaluated retrospectively. Manometric analysis was performed in all patients and 24-hour ambulatory pH-metry in 91 of them.
RESULTS: The mean age of the patients was 42.6+/-13 years and 51% were female. While 102 (39.4%) of the patients had normal esophageal motility, 122 (47.1%) had gastroesophageal reflux-related dysmotility (22% with ineffective esophageal motility, 25.1% with hypotensive lower esophageal sphincter). Primary esophageal motility disorders were detected in 29 (11.2%) patients (4 achalasia, 24 uncoordinated contractions and 1 nutcracker esophagus). Six patients had secondary dysmotility caused by scleroderma. Pathologic reflux was detected in 54 (59.3%) patients in whom pH-metry was performed.
CONCLUSIONS: Our results support that manometry and pH-metry must be performed before surgery in gastroesophageal reflux disease.

Entities:  

Mesh:

Year:  2009        PMID: 20084569     DOI: 10.4318/tjg.2009.0023

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  1 in total

1.  Gastroesophageal reflux in bronchiectasis and the effect of anti-reflux treatment.

Authors:  Zhi-Wei Hu; Zhong-Gao Wang; Yu Zhang; Ji-Min Wu; Jian-Jun Liu; Fang-Fang Lu; Guang-Chang Zhu; Wei-Tao Liang
Journal:  BMC Pulm Med       Date:  2013-06-03       Impact factor: 3.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.